Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 112 (RNA5SP112)

Target
RNA5SP112
Molecular classification
Other, Pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 112 (RNA5SP112) is a genomic DNA segment classified as a pseudogene of the 5S ribosomal RNA (rRNA) gene. 5S rRNA is an approximately 120-nucleotide structural RNA essential for ribosome function, but pseudogenes like RNA5SP112 are nonfunctional remnants that do not produce mature 5S rRNA or any protein product[2][5][6]. Pseudogenes are typically the result of duplication or retrotransposition events and lack the necessary regulatory sequences or structural integrity for function. While some pseudogenes are transcribed, most lack established biological roles. There is no evidence that RNA5SP112 plays a part in normal physiology or disease, or that it is a therapeutic target. Recent research suggests that some pseudogene transcripts can act as competitive endogenous RNAs or have regulatory effects, but no such activity has been identified for RNA5SP112. More broadly, profiling pseudogene expression is emerging in cancer biomarker research, but RNA5SP112 itself has no established clinical significance[4][6].

Other names
RN5S112RNA5SP112RNA, 5S ribosomal 112
02

Mechanism of action

Not applicable (no direct functional or drug target activity)

03

Biological functions

None (as a pseudogene, it does not encode a functional product)May potentially serve regulatory non-coding roles (e.g., as competitive endogenous RNA, but no evidence for RNA5SP112 specifically)
04

Disease associations

Other (Expression of pseudogenes, in general, is increasingly explored for correlation with cancer subtypes and prognosis, but no evidence supports a direct functional or disease association for RNA5SP112)
05

Safety considerations

Not applicable
06

Interacting drugs

None known (pseudogenes are not targeted by drugs)
07

Biomarkers

None known for RNA5SP112 specificallyPseudogene expression levels broadly may be useful as cancer prognostic biomarkers, mainly in research settings; no clinical evidence for this specific pseudogene

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 112 (RNA5SP112).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 112 (RNA5SP112).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call